If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlobalData Regulatory News (DATA)

Share Price Information for GlobalData (DATA)

Share Price is delayed by 15 minutes
Get Live Data
81.00    2.20 (2.79%)
Bid:
79.20
Ask:
80.80
Spread: 1.60 (2.02%)
Market Cap: £562.36m
DATA Live PriceLast checked at - London Stock Exchange

Intraday GlobalData Share Chart

Transaction in Own Shares

23 Aug 2024 07:00

RNS Number : 4977B
GlobalData PLC
23 August 2024
 

23 August 2024

 

 

GlobalData Plc

 

Transaction in Own Shares

 

 

GlobalData Plc ('GlobalData' or the 'Group') announces that, in accordance with the terms of its share buyback programme announced and commenced on 31 July 2024 (the "Share Buyback Programme"), the Company purchased the following number of its ordinary shares of £0.0001 each through Panmure Liberum Limited.

 

 

Date of purchase:

22 August 2024

Aggregate number of ordinary shares of £0.0001 each purchased:

275,000

Lowest price paid per share (GBp):

222.0

Highest price paid per share (GBp):

222.0

Volume weighted average price paid per share (GBp):

222.0

 

The Group will cancel the repurchased shares. Following the purchase of these shares, the remaining number of ordinary shares in issue will be 841,518,898 and the Group holds no ordinary shares in treasury. Therefore, the total voting rights in GlobalData will be 841,518,898. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Panmure Liberum Limited as part of the Share Buyback Programme.

 

Aggregate Information:

 

Venue

Volume-weighted average price (pence per share)

Aggregated volume

XLON

222.0

275,000

 

Individual transactions:

 

Number of shares purchased

Transaction price (pence per share)

Time of transaction

Venue

275,000

222.0

10:46:16

AIMX

 

 

ENQUIRIES

 

GlobalData Plc

Mike Danson, Chief Executive Officer

0207 936 6400

Graham Lilley, Chief Financial Officer

J.P. Morgan Cazenove (Nomad, Joint Broker)

0203 493 8000

Bill Hutchings

Mose Adigun

Panmure Liberum (Joint Broker)

0207 886 2500

Rupert Dearden

Dougie McLeod

Investec Bank plc (Joint Broker)

Henry Reast

Virginia Bull 

0207 597 5970

 

FTI Consulting (Financial PR)

0203 727 1000

Edward Bridges

globaldata@fticonsulting.com

Dwight Burden

Emma Hall

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAKPAASFLEFA
Date   Source Headline
31st Mar 20167:00 amRNSAnnual Report and Accounts and Notice of AGM
17th Mar 20166:12 pmRNSTransaction in Own Shares
11th Mar 20165:07 pmRNSDirector/PDMR Shareholding
8th Mar 20165:56 pmRNSDirector's Dealings
1st Mar 20167:00 amRNSDirectorate Change
1st Mar 20167:00 amRNSFinal Results
26th Jan 201611:02 amRNSHoldings in Company and Director Shareholding
25th Jan 20168:00 amRNSCompletion of Acquisition and Disposal
19th Jan 20161:31 pmRNSResult of General Meeting
23rd Dec 20157:00 amRNSAcquisition and Disposal
18th Dec 20157:00 amRNSPossible Acquisition and Disposal
1st Sep 20157:03 amRNSCompletion of Acquisition
27th Jul 20157:01 amRNSInterim Results
27th Jul 20157:00 amRNSAcquisition of Business Assets from Informa plc
21st Apr 201512:52 pmRNSResult of Annual General Meeting
27th Mar 20157:00 amRNSAnnual Report and Accounts and Notice of AGM
2nd Mar 20157:00 amRNSFinal Results
4th Dec 20147:00 amRNSPre-Close Trading Update
7th Oct 20142:36 pmRNSHolding(s) in Company
5th Aug 20143:02 pmRNSNotification of Major Interests in Shares
30th Jul 20145:06 pmRNSAcquisition Completion
28th Jul 20147:00 amRNSInterim Results
17th Jul 20141:39 pmRNSNew Banking Facilities
8th Jul 20147:00 amRNSAcquisition of CurrentAnalysis Inc.
23rd Apr 20147:34 amRNSResult of AGM
31st Mar 20147:00 amRNSIssue of Equity
14th Mar 20147:00 amRNSIssue of Equity
7th Mar 201412:21 pmRNSIssue of Equity and Director's Dealings
24th Feb 20147:00 amRNSPreliminary Results
2nd Jan 20147:00 amRNSAcquisition
10th Dec 20137:00 amRNSAcquisition
29th Jul 20137:00 amRNSInterim Results
24th May 20139:05 amRNSCapital Reduction
22nd May 201311:18 amRNSCapital Reduction
24th Apr 20131:09 pmRNSResult of AGM and GM
12th Apr 20137:00 amRNSAdditional listing
26th Mar 20137:00 amRNSProposed Capital Reduction and Consolidation
25th Feb 20137:00 amRNSPreliminary Results
12th Nov 20127:00 amRNSAdviser Change of Name
26th Jul 20127:00 amRNSInterim Statement
5th Jul 20127:00 amRNSTrading Update
30th Apr 20127:00 amRNSDirectors' Dealings
27th Apr 201210:53 amRNSResult of AGM and EGM
5th Apr 20127:00 amRNSProposed Placing
2nd Apr 20122:46 pmRNSAnnual report and accounts and Notice of AGM
22nd Mar 201212:57 pmRNSDirector/PDMR Shareholding
6th Mar 20127:09 amRNSFinal Results
5th Mar 20127:00 amRNSChange of Adviser
27th Sep 201111:33 amRNSDirector/PDMR Shareholding
1st Aug 20117:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.